Ngā hua rapu - Colleen Mockbee

  • E whakaatu ana i te 1 - 5 hua o te 5
Whakamahine hua
  1. 1
    Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model

    Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model mā Yifei Zhong, Mylène Pouliot, Anne-Marie Downey, Colleen Mockbee, Debasish Roychowdhury, W Wierzbicki, Simon Authier

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation

    Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation mā Nicholas P. Clayton, Richard Khan-Malek, Charles A. Dangler, Donghui Zhang, Alexis Ascah, Malcolm Gains, Brent Gardner, Colleen Mockbee, Joan Keutzer, J McManus, Simon Authier

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer mā Siqing Fu, Bradley R. Corr, Kerry Culm-Merdek, Colleen Mockbee, Hagop Youssoufian, Robert Stagg, R. Wendel Naumann, Robert M. Wenham, Rafael D. Rosengarten, Laura E. Benjamin, Erika Hamilton, Kathleen N. Moore

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

    Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer mā Neil A. O’Brien, Dylan Conklin, Richard P. Beckmann, Tong Luo, Kevin Chau, Josh D. Thomas, Ann Mc Nulty, Christophe C. Marchal, Ondrej Kalous, Erika von Euw, Sara A. Hurvitz, Colleen Mockbee, Dennis J. Slamon

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial

    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial mā David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, Jay Lohrey, Syed Mohammad Ali Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, E. Siglinsky, Anil K. Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura E. Benjamin, Rolf A. Brekken, Chul Ahn, Amit G. Singal, Hao Zhu, Yujin Hoshida, Adam C. Yopp

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: